1Looney WJ. Role of Stenotrophomonas mahophilia in hospital-acquired infeetion[J].Br J Biomed Sci, 2005,62(3) : 145- 154.
2Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia [J]. Clin Microbiol Rev,1998,11 ( 1 ) : 57-80.
3Senol E. Stenotrophomonas maltophilia :the significance and role as a nosocomial pathogen[J]. J Hosp Inject, 2004, 57 (1) :1-7.
4de Oliveria-garcia D,DallAgnol M,Rosales M, et al. Fimbriae and adherence of Stenotrophomonas tnaltophilia to epithelial cells and to abiotic surfaces[J]. Cell Microbiol, 2003,5 (9) 625-636.
5Caylan R, Kaklikkaya N, Aydin K, et al. An epidemlological analysis of Stenotrophomonas maltophilia strains in a university hospital[J]. Jan J Infect Dis,2004,57(2)37-40.
6Calza L, Manfredi R, Childo E. Stenotrophomonas(Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection:a 10-year surveillance stody[J]. Infection,2003, 31(3):155 -161.
7Friedman ND, Korraan TM, Fairley CK, et al. Bacteraemia due to Stenotrophomonas maltophilia : an analysis of 45 episodes[J]. J Infect, 2002:45(1):47-53.
8Gulmez D, Haseelik G. Stenotrophomonas maltophilia :anti- microbial resistance and molecular typing of an emerging pathogen in a Turkish university hospital[J]. Clin Microbiol Infect,2005,11(11) :880-886,.
9Garcia Paez JI, Tengan M, Barone AA, etal. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia [J]. Ear Clin Microbiol Infect Dis,2008,27(10)901 -906.
10Aisenberg G, Rolston KV, Dickey BF, et al. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection,1997- 2004[J]. Eur Clin Microbiol Infect Dis, 2007,26(9) : 13-20.
2Barlow RS,Pemberton JM,Desmarchelier PM,et al.Isolation and characterization of integron-containing bacteria without antibiotic selection[J].Antimicrob Agents Chemother,2004,48(3):838-842.
3Rowe-Magnus DA,Mazel D.The role of integrons in antibiotic resistance gene capture[J].Int J Med Microbiol,2002,292(2):115-125.
4Rowe-Magnus DA,Guerout AM,Mazel D.Bacterial resistance evolution by recruitment of super-integron gene cassettes[J].Mol Microbiol,2002,43(6):1657-1669.
5Leverstein-van-Hall MA,M-Blok HE,T-Donderss AR,et al.Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin[J].J Infect Dis,2003,187(2):251-259.
6Chang LL,Chen HF,Chang CY,et al.Contribution of integrons,and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia[J].J Antimicrob Chemother,2004,53(3):518-521.
2Waters VJ, Gomez MI, Soong G, et al. Immunostimulatory Properties of the emerging pathogen Stenotrophomonas malto- philia [J]. Infect Immun, 2007,75 : 1698-1703.
3Tatman-Otkun M, Gurcan S, Ozer B, et al. The antimicrobi al susceptibility of Stenotrophomonas maltophilia isolates u sing three different methods and their genetic relatedness[J]. BMC Microbiology, 2005,5 : 24-29.
4Looney WJ, Narita M, Muhlemann K. Stenotrophomonas malto- philia : an emerging opportunist human pathogen[J]. Lancet Infect Dis,2009,9(5) :312-323.
5Rolston KV, Kontoyiannis DP, Yadegarynia D, et al. Non fermentative gram-negative bacilli in cancer patients: increas- ing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones[J]. Diagn Microbiol Infect Dis,2005,51 (3) :215-218.
6Venditti M, Monaco M, Micozzi A, et al. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood iso- lates from patients with hematologic malignancies[J]. Clin Microbiol Infect, 2001,7(1) : 37-39.
7Paez JI, Tengan FM, Barone AA, et al. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia [J]. Eur J Clin Mierobiol InfectDis, 2008, 27 (10): 901-906.
10Petrosillo N,Ioannidou E,Falagas ME. Colistin montherapy vs combination therapy:evidence from microbiological,animal and clinical studies[J].Clinical Microbiology and Infection,2008,(09):816-827.doi:10.1111/j.1469-0691.2008.02061.x.
